Major organizations including the American Heart Association and Campaign for Tobacco-Free Kids have issued critical statements following the Trump administration’s 2021 budget proposal, which aims to abolish the FDA Center for Tobacco Products and establish a new agency within the Department of Health and Human Services.

Physicians who treat individuals with AFib may mistake gastrointestinal bleeding as a side effect of their patients’ blood thinners when it may, in fact, be an early warning sign for bowel cancer, according to a new study.

A Massachusetts General Hospital physician was instrumental in getting two new medical emojis—an anatomically correct heart and a pair of lungs—approved for an update later this year, the Boston Globe reported Feb. 4.

A possible shortage of heparin, one of the most popular blood thinners on the market, is threatening the U.S., according to a viewpoint published in The Lancet on Jan. 23.

The jury is out: vaping, or e-cigarette use, is a national epidemic in the U.S.

A recent meta-analysis published in the Journal of Vascular and Interventional Radiology supports evidence that paclitaxel-coated balloons may pose more risk than reward for patients with symptoms of critical limb ischemia.

Biotech company BioMarin Pharmaceutical is considering a price point of between $2 million and $3 million for its novel experimental gene therapy for hemophilia patients, the Wall Street Journal reported Jan. 16.

A review published in the Journal of the American College of Cardiology this month suggests that an excess of 2 million patients with cardiovascular disease also use marijuana.